ATLANTA--(BUSINESS WIRE)--Aug. 10, 2006--MIV Therapeutics (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, will unveil technology to address multiple revenue opportunities in the $23 billion orthopedic device market at the upcoming World Orthopedic Organization (SICOT) conference in Buenos Aires, later this month.
